Available in 10 and 50 dose bottles.
Safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.
Modified Live Virus IBR & PI3. For the active immunization of healthy cattle against IBR & PI3. Intranasal administration stimulates high levels of local antibodies as well as circulating antibodies.
Dosage: 1 mL in each nostril using separate disposable cannula for each animal. 21 day slaughter withhold.
Nasalgen IP
Merck Animal Health
MERCK ANIMAL HEALTH
Intervet Inc.2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service: 800-521-5767 Order Desk: 800-648-2118 Technical Service (Companion Animal): 800-224-5318 Technical Service (Livestock): 800-211-3573 Fax: 973-937-5557 Website: www.merck-animal-health-usa.com THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details. NASALGEN® IP
Intervet/Merck Animal Health
Bovine Rhinotracheitis-Parainfluenza 3 Vaccine
Modified Live Virus
Cattle Vaccine
Indications: Nasalgen® IP vaccine is for the vaccination of healthy cattle 5 months of age or older as an aid in the prevention of disease caused by infectious bovine rhinotracheitis and parainfluenza 3 virus.
Dosage and Administration: Aseptically rehydrate Nasalgen® IP vaccine with the enclosed diluent. Administer 2 mL into one nostril or 1 mL into each nostril for a 2 mL dose, using a separate disposable cannula for each animal.
Nasalgen® IP vaccine is safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.
FOR INTRANASAL USE ONLY
FOR ANIMAL USE ONLY
Caution: Store at 2°-7°C (35°-45°F). Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes, needles or cannulas. Burn container and all unused contents. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use, treat with epinephrine. Contains gentamicin as a preservative.
Precaution: This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103 USA
U.S. Veterinary License No. 165A
1 800 521-5767
For patent information:
http://www.merck.com/product/patent/home.html
Code
10x1 Dose Vials of Vaccine
Rehydrate each to 2 mL
065384
044845-12
10 Doses
20 mL
149730
145763-01
50 Doses
100 mL
065387
126961-13
CPN: 1047133.4